serine has been researched along with Leukemia, Myeloid, Acute in 20 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 7 (35.00) | 2.80 |
Authors | Studies |
---|---|
Kramer, MH | 1 |
Zhang, Q | 1 |
Sprung, R | 1 |
Day, RB | 1 |
Erdmann-Gilmore, P | 1 |
Li, Y | 1 |
Xu, Z | 1 |
Helton, NM | 1 |
George, DR | 1 |
Mi, Y | 1 |
Westervelt, P | 1 |
Payton, JE | 1 |
Ramakrishnan, SM | 1 |
Miller, CA | 1 |
Link, DC | 1 |
DiPersio, JF | 1 |
Walter, MJ | 1 |
Townsend, RR | 1 |
Ley, TJ | 1 |
Murray, HC | 1 |
Miller, K | 1 |
Brzozowski, JS | 1 |
Kahl, RGS | 1 |
Smith, ND | 1 |
Humphrey, SJ | 1 |
Dun, MD | 1 |
Verrills, NM | 1 |
Paredes, R | 1 |
Kelly, JR | 1 |
Geary, B | 1 |
Almarzouq, B | 1 |
Schneider, M | 1 |
Pearson, S | 1 |
Narayanan, P | 1 |
Williamson, A | 1 |
Lovell, SC | 1 |
Wiseman, DH | 1 |
Chadwick, JA | 1 |
Jones, NJ | 1 |
Kustikova, O | 1 |
Schambach, A | 1 |
Garner, T | 1 |
Amaral, FMR | 1 |
Pierce, A | 1 |
Stevens, A | 1 |
Somervaille, TCP | 1 |
Whetton, AD | 1 |
Meyer, S | 1 |
Jeong, S | 1 |
Savino, AM | 1 |
Chirayil, R | 1 |
Barin, E | 1 |
Cheng, Y | 1 |
Park, SM | 1 |
Schurer, A | 1 |
Mullarky, E | 1 |
Cantley, LC | 1 |
Kharas, MG | 1 |
Keshari, KR | 1 |
Bjelosevic, S | 1 |
Gruber, E | 1 |
Newbold, A | 1 |
Shembrey, C | 1 |
Devlin, JR | 1 |
Hogg, SJ | 1 |
Kats, L | 1 |
Todorovski, I | 1 |
Fan, Z | 1 |
Abrehart, TC | 1 |
Pomilio, G | 1 |
Wei, A | 1 |
Gregory, GP | 1 |
Vervoort, SJ | 1 |
Brown, KK | 1 |
Johnstone, RW | 1 |
Thacker, G | 1 |
Mishra, M | 1 |
Sharma, A | 1 |
Singh, AK | 1 |
Sanyal, S | 1 |
Trivedi, AK | 1 |
Di Marcantonio, D | 1 |
Martinez, E | 1 |
Kanefsky, JS | 1 |
Huhn, JM | 1 |
Gabbasov, R | 1 |
Gupta, A | 1 |
Krais, JJ | 1 |
Peri, S | 1 |
Tan, Y | 1 |
Skorski, T | 1 |
Dorrance, A | 1 |
Garzon, R | 1 |
Goldman, AR | 1 |
Tang, HY | 1 |
Johnson, N | 1 |
Sykes, SM | 1 |
Takami, M | 1 |
Katayama, K | 1 |
Noguchi, K | 1 |
Sugimoto, Y | 1 |
Yuan, LL | 1 |
Green, AS | 2 |
Bertoli, S | 1 |
Grimal, F | 1 |
Mansat-De Mas, V | 1 |
Dozier, C | 1 |
Tamburini, J | 2 |
Récher, C | 2 |
Didier, C | 1 |
Manenti, S | 1 |
Brault, L | 1 |
Rovó, A | 1 |
Decker, S | 1 |
Dierks, C | 1 |
Tzankov, A | 1 |
Schwaller, J | 1 |
Natarajan, K | 1 |
Xie, Y | 1 |
Burcu, M | 1 |
Linn, DE | 1 |
Qiu, Y | 1 |
Baer, MR | 1 |
Huang, Y | 1 |
Thoms, JA | 1 |
Tursky, ML | 1 |
Knezevic, K | 1 |
Beck, D | 1 |
Chandrakanthan, V | 1 |
Suryani, S | 1 |
Olivier, J | 1 |
Boulton, A | 1 |
Glaros, EN | 1 |
Thomas, SR | 1 |
Lock, RB | 1 |
MacKenzie, KL | 1 |
Bushweller, JH | 1 |
Wong, JW | 1 |
Pimanda, JE | 1 |
Gallay, N | 1 |
Dos Santos, C | 1 |
Cuzin, L | 1 |
Bousquet, M | 1 |
Simmonet Gouy, V | 1 |
Chaussade, C | 1 |
Attal, M | 1 |
Payrastre, B | 1 |
Demur, C | 1 |
Chapuis, N | 1 |
Park, S | 1 |
Leotoing, L | 1 |
Verdier, F | 1 |
Bardet, V | 1 |
Willems, L | 1 |
Agou, F | 1 |
Ifrah, N | 1 |
Dreyfus, F | 1 |
Bismuth, G | 1 |
Baud, V | 1 |
Lacombe, C | 1 |
Mayeux, P | 1 |
Bouscary, D | 1 |
Fragliasso, V | 1 |
Chiodo, Y | 1 |
Ferrari-Amorotti, G | 1 |
Soliera, AR | 1 |
Manzotti, G | 1 |
Cattelani, S | 1 |
Candini, O | 1 |
Grisendi, G | 1 |
Vergalli, J | 1 |
Mariani, SA | 1 |
Guerzoni, C | 1 |
Calabretta, B | 1 |
Radomska, HS | 2 |
Alberich-Jordà, M | 1 |
Will, B | 1 |
Gonzalez, D | 1 |
Delwel, R | 1 |
Tenen, DG | 2 |
Simone, F | 1 |
Luo, RT | 1 |
Polak, PE | 1 |
Kaberlein, JJ | 1 |
Thirman, MJ | 1 |
Bassères, DS | 1 |
Zheng, R | 1 |
Zhang, P | 1 |
Dayaram, T | 1 |
Yamamoto, Y | 1 |
Sternberg, DW | 1 |
Lokker, N | 1 |
Giese, NA | 1 |
Bohlander, SK | 1 |
Schnittger, S | 1 |
Delmotte, MH | 1 |
Davis, RJ | 1 |
Small, D | 1 |
Hiddemann, W | 1 |
Gilliland, DG | 1 |
Odgerel, T | 1 |
Kikuchi, J | 1 |
Wada, T | 1 |
Shimizu, R | 1 |
Futaki, K | 1 |
Kano, Y | 1 |
Furukawa, Y | 1 |
Dimitrov, NV | 1 |
Hansz, J | 1 |
Toth, MA | 1 |
Bartolotta, B | 1 |
20 other studies available for serine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
Topics: fms-Like Tyrosine Kinase 3; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethyl | 2022 |
Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia.
Topics: Animals; Apoptosis; Cell Line, Tumor; Dasatinib; DNA; DNA-Activated Protein Kinase; Leukemia, Myeloi | 2023 |
EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewal.
Topics: Alcohol Oxidoreductases; Cell Self Renewal; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; D | 2020 |
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells.
Topics: Animals; Fructose; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Congenic; Mice, Inbred NOD; Serine; | 2021 |
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid Leukemia.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Mye | 2021 |
CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia.
Topics: CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Line, Tumor; Cyclin-Dependent Kinase 2; | 2021 |
ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia.
Topics: Activating Transcription Factor 3; Cell Cycle; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; N | 2021 |
Protein kinase C alpha-mediated phosphorylation of PIM-1L promotes the survival and proliferation of acute myeloid leukemia cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, Myeloid, Acute; Phosphorylation; | 2018 |
Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia.
Topics: Cell Line, Tumor; Checkpoint Kinase 1; fms-Like Tyrosine Kinase 3; Gene Duplication; Humans; Intrace | 2014 |
CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cell Adhesion; Female; Humans; Leukemia, Myeloid, Acute; | 2014 |
Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication.
Topics: Animals; Apoptosis; Calnexin; Cell Line; Cell Proliferation; Endoplasmic Reticulum; fms-Like Tyrosin | 2013 |
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation.
Topics: Binding Sites; Cell Line, Tumor; Cell Proliferation; Hematopoietic Stem Cells; Humans; Leukemia; Leu | 2016 |
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia.
Topics: Adolescent; Adult; Apoptosis; Cell Proliferation; Cytogenetic Analysis; Female; Humans; Leukemia, My | 2009 |
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
Topics: Apoptosis; Cell Nucleus; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Forkhead Bo | 2010 |
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
Topics: Amino Acid Substitution; Base Sequence; Benzamides; CCAAT-Enhancer-Binding Protein-alpha; Cell Diffe | 2012 |
Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.
Topics: Animals; Base Sequence; CCAAT-Enhancer-Binding Protein-alpha; CDC2 Protein Kinase; Cell Differentiat | 2012 |
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Binding Sites; Blotting, Northern; Bone Marrow; Cell Nu | 2003 |
Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.
Topics: Aged; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line; Enzyme Activation; Fema | 2006 |
The FLT3 inhibitor PKC412 exerts differential cell cycle effects on leukemic cells depending on the presence of FLT3 mutations.
Topics: Apoptosis; bcl-Associated Death Protein; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Pro | 2008 |
Serine and aspartic acid metabolism in leukemic leukocytes: correlation to effectiveness of therapy.
Topics: Adult; Aged; Aspartic Acid; Blood Proteins; Carbon Dioxide; Carbon Isotopes; Female; Glycine; Humans | 1971 |